Want to join the conversation?
$PRGS cut its 2016 non-GAAP revenue guidance to range of $414-420MM from previous forecast of $427-433MM, and its non-GAAP EPS outlook to range of $1.57-1.63 from previous estimate of $1.59-1.65. For 2Q16, $PRGS expects non-GAAP revenue of $93-96MM and non-GAAP EPS of $0.26-0.29.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?